BioCardia, Inc. (BCDA)
NASDAQ·Healthcare·Biotechnology
$1.16
+0.00%
Mkt Cap $7.42M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | $25.00K | — | — | -$0.20 | -$0.06 | +70.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.25 | -$0.24 | +4.00% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.25 | -$0.40 | -60.00% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.39 | -$0.59 | -51.28% | — | — |
| Q1 2025 Mar 26, 2025 | $22.50K | $25.00K | +11.11% | -$0.87 | -$0.25 | +71.26% | — | — |
| Q4 2024 Nov 13, 2024 | $20.00K | $58.00K | +190.00% | -$1.19 | -$0.61 | +48.74% | — | — |
| Q3 2024 Aug 13, 2024 | $50.00K | $3.00K | -94.00% | -$0.10 | -$0.88 | -780.00% | — | — |
| Q2 2024 May 14, 2024 | — | $55.00K | — | -$3.00 | -$1.35 | +55.00% | — | — |
| Q1 2024 Mar 27, 2024 | $90.00K | $13.00K | -85.56% | -$1.65 | -$1.35 | +18.18% | — | — |
| Q4 2023 Nov 8, 2023 | $90.00K | $357.00K | +296.67% | -$1.80 | -$1.80 | +0.00% | — | — |
| Q3 2023 Aug 9, 2023 | $120.00K | $43.00K | -64.17% | -$2.25 | -$2.55 | -13.33% | — | — |
| Q2 2023 May 10, 2023 | $340.00K | $64.00K | -81.18% | -$1.95 | -$2.55 | -30.77% | — | — |
| Q1 2023 Mar 29, 2023 | $100.00K | $106.00K | +6.00% | -$2.70 | -$2.40 | +11.11% | — | — |
| Q4 2022 Nov 9, 2022 | $113.00K | $212.00K | +87.61% | -$3.45 | -$2.55 | +26.09% | — | — |
| Q3 2022 Aug 10, 2022 | $92.00K | $974.00K | +958.70% | -$4.20 | -$2.10 | +50.00% | — | — |
| Q2 2022 May 11, 2022 | $190.00K | $60.00K | -68.42% | -$2.25 | -$2.85 | -26.67% | — | — |
| Q1 2022 Mar 29, 2022 | $32.75K | $79.00K | +141.22% | -$3.15 | -$3.15 | +0.00% | — | — |
| Q4 2021 Nov 10, 2021 | — | $821.00K | — | -$0.21 | -$2.40 | -1042.86% | — | — |
| Q3 2021 Aug 12, 2021 | $69.00K | $69.00K | +0.00% | -$3.15 | -$3.00 | +4.76% | — | — |
| Q2 2021 May 13, 2021 | $57.50K | $46.00K | -20.00% | -$3.15 | -$2.70 | +14.29% | — | — |